{"name":"Dunamenti REK Istenhegyi IVF Center","slug":"dunamenti-rek-istenhegyi-ivf-center","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"1978-01-01","label":"Progesterone first approved","drug":"Progesterone","drugSlug":"progesterone-plus-hcg","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"higher dose recFSH","genericName":"higher dose recFSH","slug":"higher-dose-recfsh","indication":"Controlled ovarian hyperstimulation in assisted reproductive technology (ART) / in vitro fertilization (IVF)","status":"marketed"},{"name":"Progesterone","genericName":"Progesterone plus HCG","slug":"progesterone-plus-hcg","indication":"Abortion","status":"marketed"},{"name":"no luteal support","genericName":"no luteal support","slug":"no-luteal-support","indication":"IVF cycle support (specific patient populations or cycle types as defined by Dunamenti REK Istenhegyi IVF Center)","status":"marketed"},{"name":"unchanged dose","genericName":"unchanged dose","slug":"unchanged-dose","indication":"Marketed for various uses","status":"marketed"}]}],"pipeline":[{"name":"higher dose recFSH","genericName":"higher dose recFSH","slug":"higher-dose-recfsh","phase":"marketed","mechanism":"Recombinant follicle-stimulating hormone (recFSH) at higher doses stimulates the ovaries to produce multiple mature eggs for assisted reproductive procedures.","indications":["Controlled ovarian hyperstimulation in assisted reproductive technology (ART) / in vitro fertilization (IVF)","Anovulation and infertility in women"],"catalyst":""},{"name":"Progesterone","genericName":"Progesterone plus HCG","slug":"progesterone-plus-hcg","phase":"marketed","mechanism":"progesterone receptor, luteinizing hormone/choriogonadotropin receptor","indications":["Abortion","Induction of labor","Menstrual disorders","Miscarriage","Pregnancy maintenance"],"catalyst":""},{"name":"no luteal support","genericName":"no luteal support","slug":"no-luteal-support","phase":"marketed","mechanism":"This is a clinical protocol or treatment approach that deliberately omits luteal phase hormonal support following ovarian stimulation in assisted reproductive technology.","indications":["IVF cycle support (specific patient populations or cycle types as defined by Dunamenti REK Istenhegyi IVF Center)"],"catalyst":""},{"name":"unchanged dose","genericName":"unchanged dose","slug":"unchanged-dose","phase":"marketed","mechanism":"The exact mechanism of unchanged dose is not well-documented.","indications":["Marketed for various uses"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":4,"phaseCounts":{"marketed":4},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}